News Opinion Off Script Stayin’ Alive and Playing It Forward: A Revision for ‘Resusci Annie’ Nicole Bart, MD, PhD December 04, 2023
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Daily News Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’ Yael L. Maxwell November 08, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Daily News Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs Caitlin E. Cox October 06, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Daily News A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival Caitlin E. Cox August 09, 2023
News Daily News SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity Todd Neale August 08, 2023
News Conference News SCCT 2023 AI Predicted to Play Major Role in Cardiac CT and CV Care in the Coming Decade Todd Neale August 03, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2023 Shelley Wood July 31, 2023
News Conference News ADA 2023 Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1 Shelley Wood June 29, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Daily News Reports of Arrhythmias, Cardiac Arrests Linked to Nonprescription Opioids Todd Neale June 09, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Conference News ACC 2023 Keto Diet Linked to Hypercholesterolemia, Higher ASCVD Risk Shelley Wood March 08, 2023
News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023